Literature DB >> 12902204

The effects of paroxetine on rat isolated vas deferens.

Ersin Yaris1, Murat Kesim, Mine Kadioglu, Nuri Ihsan Kalyoncu, Cunay Ulku, Rasin Ozyavuz.   

Abstract

The aim of the present study is to evaluate whether paroxetine (a selective serotonin re-uptake inhibitor) can modify the contractile responses of isolated vas deferens. Some contractile agents, potassium chloride (KCl), adenosine 5'-triphosphate (ATP), noradrenaline (NA), and electrical field stimulation (EFS) caused contractions both in epididymal and prostatic portions of vas deferens. Paroxetine (PX) in concentrations 10(-7) and 10(-6)M potentiated the contractions to KCl and ATP only in epididymal portion but in higher concentrations (10(-5) and 10(-4)M) inhibited the responses in both portions. NA responses were inhibited by PX in all concentrations used, both in prostatic and epididymal portions. Prazosin (PR), an alpha adrenergic receptor blocking agent, inhibited PX-induced potentiation observed for higher concentrations of KCl. PR also inhibited PX-induced potentiation on the responses to ATP in epididymal portion. Pretreatment with PX (10(-7) to 10(-6)M) increased the contractions to EFS but in 10(-5) and 10(-4)M concentrations inhibited them. Even though the preparations were washed out, the inhibited responses of contractile agents could not be restored. After a washout period for PX, when Bay K 8644 (calcium channel activator) was added to the bath medium, the contractile responses to KCl were partially restored. In calcium-free medium, KCl caused contractions in concentrations higher than 80 mM with lower amplitudes which were not affected by PX. Reserpinization did not change the inhibitory pattern of PX's effect on exogenously applied NA in all concentrations tested. In reserpinized rats, the potentiation caused by PX in exogenously applied ATP responses was not observed. In conclusion, we can say that PX has two different effects: inhibition and potentiation of contractions to various agonists. The inhibitory effect of the drug can be explained by a calcium channel blocking activity. The potentiating effect of the drug is mainly related to its presynaptic action, such as NA re-uptake inhibitory effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902204     DOI: 10.1016/s1043-6618(03)00157-9

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  4 in total

Review 1.  Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.

Authors:  Andrea L Suárez; Jamison D Feramisco; John Koo; Martin Steinhoff
Journal:  Acta Derm Venereol       Date:  2012-01       Impact factor: 4.437

Review 2.  The potential action of SSRIs in the treatment of skin diseases including atopic dermatitis and slow-healing wounds.

Authors:  Aneta Kiecka; Marian Szczepanik
Journal:  Pharmacol Rep       Date:  2022-10-07       Impact factor: 3.919

3.  Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate.

Authors:  Lauren K Parker; Julia A Shanks; James A G Kennard; Keith L Brain
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

Review 4.  Neuroimmunological mechanism of pruritus in atopic dermatitis focused on the role of serotonin.

Authors:  Kwangmi Kim
Journal:  Biomol Ther (Seoul)       Date:  2012-11       Impact factor: 4.634

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.